期刊文献+
共找到147篇文章
< 1 2 8 >
每页显示 20 50 100
Design,delivery and efficacy testing of therapeutic nucleic acids used to inhibit hepatitis C virus gene expression in vitro and in vivo 被引量:9
1
作者 Wolfgang H.Caselmann Matthias Serwe +3 位作者 Thomas Lehmann János Ludwig Brian S.Sproat Joachim W.Engels 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第5期626-629,共4页
Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be ... Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be treated effectively.Toimprove this response rate we used antisensetechnologies to inhibit HCV translation as possibleadditional option for experimental treatment.Antisense oligodeoxynucleotides(ODN) are 展开更多
关键词 hepatitis C-like viruses/therapy gene expression in VITRO in vivo nucleic acids/therapeutic use CYTOMEGALOVIRUS
下载PDF
Therapeutic and Medicinal Uses of <i>Aloe vera</i>: A Review 被引量:5
2
作者 Pankaj K. Sahu Deen Dayal Giri +5 位作者 Ritu Singh Priyanka Pandey Sharmistha Gupta Atul Kumar Shrivastava Ajay Kumar Kapil Dev Pandey 《Pharmacology & Pharmacy》 2013年第8期599-610,共12页
The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, ... The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, minerals, enzymes, amino acids, natural sugars and other bioactive compounds with emollient, purgative, anti-microbial, anti inflammatory, antioxidant, aphrodisiac, anti-helmenthic, antifungal, antiseptic and cosmetic values for health care. This plant has potential to cure sunburns, burns and minor cuts, and even skin cancer. The external use in cosmetic primarily acts as skin healer and prevents injury of epithelial tissues, cures acne and gives a youthful glow to skin, also acts as extremely powerful laxative. 展开更多
关键词 ALOE vera Antimicrobial therapeutic MEDICINAL useS Cosmetic Application
下载PDF
Continuous Wear of Hydrogel Contact Lenses for Therapeutic Use
3
作者 Daisuke Kudo Hiroshi Toshida +1 位作者 Toshihiko Ohta Akira Murakami 《Open Journal of Ophthalmology》 2012年第4期110-113,共4页
Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one w... Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one week of continuous therapeutic wear during 10 years. The reason for prescription of CLs, the primary disease, the duration of CL wear and the complications were assessed retrospectively. Results: The predominant reason for prescription of CLs was relief of pain or a foreign-body sensation (62.3%) and protection of the corneal epithelium (20.6%). The primary disease was post-penetrating keratoplasty (36.8%), followed by corneal epithelial erosion (14.5%), post-lamellar keratoplasty (14.0%) and bullous keratopathy (12.2%). The average duration of wearing single lens was 6.5 ± 3.2 days. The average duration of wearing CLs in total was 9.2 ± 10.7 months. The most frequent problem associated with continuous wear of CLs was their dropping out of CLs (12.3%). The complications associated with CLs included conjunctivitis with papillary hyperplasia, corneal erosion and superficial punctate keratitis, but corneal ulcer and corneal infiltrates were not found. Conclusion: Serious complications were not shown changing the lenses every week to keep to the prescribed time limit for continuous therapeutic wear, even if corneal epithelial barrier function is impaired. 展开更多
关键词 therapeutic use BANDAGE Soft Contact LENS CONTINUOUS WEAR COMPLICATION
下载PDF
Comparison of long-lasting therapeutic effects between succimer and penicillamine on hepatolenticular degeneration 被引量:3
4
作者 REN Ming Shan, ZHANG Zhi, WU Jun Xia, LI Fei, XUE Ben Chun and YANG Ren Min 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第6期75-77,共3页
AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. ... AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. Group A ( n =60) received Suc 750mg , po. bid. Group B ( n =60) received Pen 250mg , po. qid. The period of maintenance treatment varied from 6 months to 3 years, averaging 1 5 years. Symptoms and therapeutic effects were evaluated by modified Goldstein scale. RESULTS The total effectiveness of group A in two different periods of treatment were 80% and 85% respectively, higher than those of group B (58% and 59% respectively) ( P <0 05). Suc also had obvious curative effects for the patients who failed in the use of Pen. There were fewer side effect in group A than in group B ( P <0 05). Suc and Pen could increase urinary copper excretion effectively and continually. CONCLUSION Suc is more effective and safer than Pen. Clinically, it can replace Pen as first choice drug for long term maintenance therapy of HLD. 展开更多
关键词 hepatolenticular degeneration/drug THERAPY succimer/therapeutic use penicillamine/therapeutic use
下载PDF
Functional dyspepsia of ulcer-dysmotility type:clinical incidence and therapeutic strategy 被引量:3
5
作者 WANG XiaoZhong and LIN GuZhen 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第4期95-96,共2页
Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhe... Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhenSubjectheaadings... 展开更多
关键词 dyspepsia/drug therapy famotidine/therapeutic use cisapride/therapeutic use peptic ULCER gastrointestinal motility
下载PDF
Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract 被引量:5
6
作者 Tsunenori Kondo Toshio Takagi Kazunari Tanabe 《World Journal of Clinical Oncology》 CAS 2015年第6期237-251,共15页
Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional n... Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional nodes for tumors of the right renal pelvis or the right upper two-thirds of the ureter. A prospective study showed that an anatomical templatebased lymphadenectomy significantly improved patient survival in tumors of the renal pelvis. This benefit was more evident for patients with p T2 stage tumors or higher. The risk of regional node recurrence is significant reduced by template-based lymphadenectomy,which is likely to be associated with improved patient survival. The removal of lymph node micrometastases is assumed to be the reason for therapeutic benefit following lymphadenectomy. The number of resected lymph nodes can be used to assess the quality of lymphadenectomy,but not to determine the extent of lymphadenectomy. The guidelines currently recommend lymphadenectomy for patients with muscle-invasive disease,even though the current recommendation grades are still low. The present limitation of lymphadenectomy is the lack of standardization of the extent of lymphadenectomy and the randomized trials. Further studies are warranted to collect the evidence to support lymphadenectomy. 展开更多
关键词 LYMPHADENECTOMY LYMPH node EXCISION UROTHELIAL carcinoma Treatment outcome therapeutic uses Diagnosis GUIDELINE
下载PDF
甲氨蝶呤联合糖皮质激素对肉芽肿性小叶性乳腺炎的疗效及不良反应分析
7
作者 陈斯琪 王蕾 +1 位作者 邹妮倩 邹素文 《中国药物应用与监测》 CAS 2024年第4期446-449,共4页
目的 分析甲氨蝶呤联合糖皮质激素对肉芽肿性小叶性乳腺炎(GLM)的疗效及不良反应。方法 回顾性选取2019年9月至2021年12月于广东省中医院和广东省妇幼保健院进行治疗的GLM患者99例,根据患者的治疗方案不同,将34例甲氨蝶呤联合糖皮质激... 目的 分析甲氨蝶呤联合糖皮质激素对肉芽肿性小叶性乳腺炎(GLM)的疗效及不良反应。方法 回顾性选取2019年9月至2021年12月于广东省中医院和广东省妇幼保健院进行治疗的GLM患者99例,根据患者的治疗方案不同,将34例甲氨蝶呤联合糖皮质激素治疗患者纳入联合治疗组,65例单纯使用糖皮质激素治疗患者纳入对照组。比较两组患者炎症因子水平、治疗效果及不良反应发生率。结果 联合治疗组的总有效率97.06%(33/34),高于对照组80.00%(52/65),差异有统计学意义(χ^(2)=4.038,P<0.05)。联合治疗组和对照组治疗后C反应蛋白(CRP)、白细胞介素-6(IL-6)、白细胞计数(WBC)水平[分别是(19.78±4.74) mg·L^(-1)、(26.46±4.24) mg·L^(-1);(22.68±5.81) pg·m L^(-1)、(33.52±6.22) pg·m L^(-1);(7.14±0.84)10~9·m L^(-1)、(8.64±0.97) 10~9·m L^(-1)],低于治疗前[分别是(34.46±8.24) mg·L^(-1)、(33.52±7.81) mg·L^(-1);(39.77±10.24)pg·m L^(-1)、(40.13±11.05) pg·m L^(-1);(10.54±2.24) 10~9·m L^(-1)、(10.72±2.51) 10~9·m L^(-1)],且治疗后联合治疗组低于对照组(t=7.146、8.419、7.638,均P<0.05)。联合治疗组不良反应发生率11.76%(4/34),低于对照组30.77%(20/65)(χ^(2)=4.390,P<0.05)。结论 甲氨蝶呤联合糖皮质激素治疗方案可显著缓解GLM患者的临床症状,且安全性较高,具有临床应用价值。 展开更多
关键词 甲氨蝶呤 糖皮质激素 肉芽肿性小叶性乳腺炎 疗效 不良反应
下载PDF
糖皮质激素治疗初诊特发性血小板减少性紫癜的效果
8
作者 李金凤 余庆玲 严严 《系统医学》 2024年第9期94-96,100,共4页
目的探究冲击量糖皮质激素在初诊特发性血小板减少性紫癜患者中的临床治疗效果。方法选取2020年1月—2023年6月江苏省建湖县人民医院收治的初诊特发性血小板减少性紫癜患者80例,信封法随机分成两组,每组40例。对照组常规治疗,观察组冲... 目的探究冲击量糖皮质激素在初诊特发性血小板减少性紫癜患者中的临床治疗效果。方法选取2020年1月—2023年6月江苏省建湖县人民医院收治的初诊特发性血小板减少性紫癜患者80例,信封法随机分成两组,每组40例。对照组常规治疗,观察组冲击量糖皮质激素治疗。对比两组治疗总有效率、免疫功能指标、相关临床指标、炎性因子指标、不良反应。结果观察组治疗总有效率为95.00%,相比对照组的77.50%显著更高,差异有统计学意义(χ^(2)=5.165,P<0.05)。观察组各项免疫功能指标水平均高于对照组,差异有统计学意义(P均<0.05)。治疗后,观察组肿瘤坏死因子-α、白细胞介素-6炎性指标水平及血小板计数、相容性人类白细胞抗原G指标水平均优于对照组,差异有统计学意义(P均<0.05)。观察组患者不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论冲击量糖皮质激素用于初诊特发性血小板减少性紫癜患者治疗中的效果相对理想,安全系数较高。 展开更多
关键词 冲击量糖皮质激素 初诊特发性血小板减少性紫癜 治疗效果
下载PDF
硫酸羟氯喹联合糖皮质激素治疗特发性膜性肾病效果及安全性研究
9
作者 李娜 蓝晓红 +1 位作者 王玥坤 高宏玉 《中国医药》 2024年第4期567-570,共4页
目的 探讨硫酸羟氯喹联合糖皮质激素治疗特发性膜性肾病(IMN)的临床效果。方法 选取东部战区总医院2021年10月至2023年2月收治的83例IMN患者,采用随机数字表法将患者分为对照组(41例)和观察组(42例)。所有患者均接受肾素-血管紧张素系... 目的 探讨硫酸羟氯喹联合糖皮质激素治疗特发性膜性肾病(IMN)的临床效果。方法 选取东部战区总医院2021年10月至2023年2月收治的83例IMN患者,采用随机数字表法将患者分为对照组(41例)和观察组(42例)。所有患者均接受肾素-血管紧张素系统抑制剂、利尿剂、抗凝药和钙调神经磷酸酶抑制剂环孢素的常规治疗。对照组在常规治疗基础上给予醋酸泼尼松片口服治疗;在对照组基础上,观察组给予硫酸羟氯喹口服治疗;2组患者均治疗12个月。比较2组临床治疗效果。检测并比较2组治疗前后总胆固醇、血肌酐、甘油三酯、白蛋白、C反应蛋白、低密度脂蛋白胆固醇、估算肾小球滤过率和24 h尿蛋白水平。比较2组不良反应发生情况。结果 治疗后,观察组临床总有效率高于对照组[92.9%(39/42)比70.7%(29/41)],差异有统计学意义(χ2=6.860,P=0.009)。治疗后,观察组总胆固醇、血肌酐、甘油三酯、C反应蛋白、24 h尿蛋白和低密度脂蛋白胆固醇水平低于对照组,差异均有统计学意义(均P<0.05);观察组白蛋白和估算肾小球滤过率水平高于对照组,差异均有统计学意义(均P<0.05)。2组不良反应发生率比较,差异无统计学意义(P=0.526)。结论 硫酸羟氯喹联合糖皮质激素治疗IMN临床效果较好,能够明显控制蛋白尿,改善肾功能,调节血脂,且安全性较好。 展开更多
关键词 特发性膜性肾病 硫酸羟氯喹 糖皮质激素 治疗效果 安全性
下载PDF
Controversies regarding transplantation of mesenchymal stem cells
10
作者 Tsvetelina Velikova Tereza Dekova Dimitrina Georgieva Miteva 《World Journal of Transplantation》 2024年第2期48-61,共14页
Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intric... Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intricate landscape of MSC controversies,drawing upon 15 years of clinical experience and research.We delve into the fundamental properties of MSCs,exploring their unique immuno-modulatory capabilities and surface markers.The heart of our inquiry lies in the controversial applications of MSC transplantation,including the perennial debate between autologous and allogeneic sources,concerns about efficacy,and lingering safety apprehensions.Moreover,we unravel the enigmatic mechanisms surro-unding MSC transplantation,such as homing,integration,and the delicate balance between differentiation and paracrine effects.We also assess the current status of clinical trials and the ever-evolving regulatory landscape.As we peer into the future,we examine emerging trends,envisioning personalized medicine and innovative delivery methods.Our review provides a balanced and informed perspective on the controversies,offering readers a clear understanding of the complexities,challenges,and potential solutions in MSC transplantation. 展开更多
关键词 Mesenchymal stem cells Transplantation controversies Regenerative medicine Autoimmune diseases Chronic inflammatory illnesses Tumor growth METASTASIS therapeutic potential Clinical use of mesenchymal stem cell
下载PDF
特发性膜性肾病患者脂代谢对免疫抑制剂联合糖皮质激素治疗效果的影响
11
作者 王琼 王申伟 《临床医学工程》 2024年第4期507-508,共2页
目的探讨特发性膜性肾病患者脂代谢对免疫抑制剂联合糖皮质激素治疗效果的影响。方法86例行免疫抑制剂联合糖皮质激素治疗的特发性膜性肾病患者根据治疗效果分为未好转组和好转组,比较两组的基线资料和脂代谢指标,分析治疗效果的相关影... 目的探讨特发性膜性肾病患者脂代谢对免疫抑制剂联合糖皮质激素治疗效果的影响。方法86例行免疫抑制剂联合糖皮质激素治疗的特发性膜性肾病患者根据治疗效果分为未好转组和好转组,比较两组的基线资料和脂代谢指标,分析治疗效果的相关影响因素。结果治疗6个月后,86例特发性膜性肾病患者中16例未好转,占比18.60%。未好转组的TC、TG水平高于好转组(P<0.05)。Logistic回归分析显示,TC、TG水平是特发性膜性肾病患者免疫抑制剂联合糖皮质激素治疗效果的影响因素(OR>1,P<0.05)。结论特发性膜性肾病患者的脂代谢水平会对免疫抑制剂联合糖皮质激素的治疗效果产生影响。 展开更多
关键词 特发性膜性肾病 脂代谢 免疫抑制剂 糖皮质激素 治疗效果
下载PDF
依巴斯汀联合吡美莫司乳膏对面部糖皮质激素依赖性皮炎的治疗效果评估分析
12
作者 马广 李海英 《中外医疗》 2024年第7期117-119,128,共4页
目的探讨面部糖皮质激素依赖性皮炎应用依巴斯汀联合吡美莫司乳膏治疗的临床效果。方法方便选取2021年1月-2023年6月肥城市中医医院收治的96例面部糖皮质激素依赖性皮炎患者为研究对象,按随机数表法分为对照组和观察组,各48例。对照组... 目的探讨面部糖皮质激素依赖性皮炎应用依巴斯汀联合吡美莫司乳膏治疗的临床效果。方法方便选取2021年1月-2023年6月肥城市中医医院收治的96例面部糖皮质激素依赖性皮炎患者为研究对象,按随机数表法分为对照组和观察组,各48例。对照组单独应用依巴斯汀治疗,观察组在对照组基础上增加吡美莫司乳膏联合治疗。比较两组治疗效果、症状评分和不良反应发生情况。结果观察组治疗总有效率(95.83%)高于对照组(83.33%),差异有统计学意义(χ^(2)=4.018,P<0.05)。观察组治疗后脱屑、色素沉着、皮肤萎缩、丘疹、脓疱、潮红评分均低于对照组,差异有统计学意义(P均<0.05)。观察组不良反应总发生率和对照组比较,差异无统计学意义(P>0.05)。结论面部糖皮质激素依赖性皮炎使用依巴斯汀联合吡美莫司乳膏治疗,临床治疗效果较好,其各种临床症状均有明显改善,且安全性良好。 展开更多
关键词 吡美莫司乳膏 面部糖皮质激素依赖性皮炎 依巴斯汀 治疗效果 症状评分
下载PDF
分析小剂量糖皮质激素联合茶碱对老年哮喘的治疗效果
13
作者 顾珊珊 胡伟联 孔倩倩 《中外医疗》 2024年第11期106-109,共4页
目的分析老年哮喘治疗中小剂量糖皮质激素+茶碱类药物的应用价值。方法随机选取2022年12月—2023年6月荣成市人民医院收治的70例老年哮喘患者为研究对象,采用随机数表法分为两组,各35例。对照组采用小剂量糖皮质激素治疗,观察组在对照... 目的分析老年哮喘治疗中小剂量糖皮质激素+茶碱类药物的应用价值。方法随机选取2022年12月—2023年6月荣成市人民医院收治的70例老年哮喘患者为研究对象,采用随机数表法分为两组,各35例。对照组采用小剂量糖皮质激素治疗,观察组在对照组基础上加用茶碱类药物。比较两组疗效、不良反应发生情况、症状消失时间、肺功能指标水平、炎性因子水平以及生活质量状况。结果观察组治疗总有效率高于对照组(97.14%vs 80.00%),差异有统计学意义(χ^(2)=5.081,P<0.05)。两组不良反应发生情况对比,差异无统计学意义(P>0.05)。观察组喘息、咳嗽、哮鸣音消失时间短于对照组,差异有统计学意义(P均<0.05)。观察组肺功能及炎性因子水平优于对照组,差异有统计学意义(P均<0.05)。观察组生活质量评分高于对照组,差异有统计学意义(P<0.05)。结论小剂量糖皮质激素联合茶碱治疗老年哮喘效果显著,可提高患者生活质量。 展开更多
关键词 小剂量糖皮质激素 茶碱 老年哮喘 治疗效果 肺功能 生活质量
下载PDF
Clinacanthus nutans:a review of the medicinal uses,pharmacology and phytochemistry 被引量:10
14
作者 Md.Ariful Alam Sahena Ferdosh +4 位作者 Kashif Ghafoor Md.Abdul Hakim Abdul Shukor Juraimi Alfi Khatib Md.Zaidul I.Sarker 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2016年第4期393-399,共7页
Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bite... Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bites,lesions caused by herpes simplex virus,diabetes,and gout in Malaysia.Indonesia.Thailand and China.Phylochemieal investigations documented the varied contents of bioaclive compounds from litis plant namely flavonoids,glycosides,glycoglyeerolipids.cerebrosides and monoacylmonogalatosylglycerol.The pharmacological experiment proved that various types of extracts and pure compounds from this species exhibited a broad range of biological properties such as anti-inflammatory,antiviral,antioxidant,and anti-diabetic activities.The lindings of toxicity study showed that extracts from this plant did not show any toxicity thus it can be used as strong therapeutic agents for specific diseased conditions.However,further experiments on chemical components and their mode of action showing biological activities are required to elucidate the complete phytochemical profile and assess to confirm their suitability tor future drugs.This review summarizes the medicinal uses,phytochemistry and pharmacology of this plant in order to explore its therapeutic potential and gaps necessitating for prospected research work. 展开更多
关键词 Clinacanthus nutans MEDICINAL useS PHYTOCHEMICALS PHARMACOLOGY therapeutic potential
下载PDF
High-intensity focused ultrasound extracorporeal ablation of liver tissuesin rabbits
15
《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第2期16-16,共1页
HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZ... HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZhaoYou1,YUYao1,B... 展开更多
关键词 LIVER neoplasms experimental/therapy ultrasonic THERAPY iodized oil/therapeutic use liver/radiation effects randomized controlled trials
下载PDF
同步糖皮质激素鼓室内注射治疗贝尔面瘫的疗效分析 被引量:1
16
作者 王建秋 尹称意 任刚 《浙江临床医学》 2023年第3期413-415,共3页
目的探讨同步糖皮质激素鼓室内注射治疗贝尔面瘫的疗效,并做对比分析。方法选取2016年12月至2019年12月本科收治的64例贝尔面瘫患者,采用1∶1对照研究的方法,对照组给予常规治疗,观察组给予在常规治疗基础上同步鼓室内注射糖皮质激素。... 目的探讨同步糖皮质激素鼓室内注射治疗贝尔面瘫的疗效,并做对比分析。方法选取2016年12月至2019年12月本科收治的64例贝尔面瘫患者,采用1∶1对照研究的方法,对照组给予常规治疗,观察组给予在常规治疗基础上同步鼓室内注射糖皮质激素。比较治疗后起效时间、面神经功能及总有效率等指标。结果治疗2周后,观察组总有效率为93.75%,对照组为75%,观察组面神经功能评分(80.38±16.09),对照组(68.84±24.30),均有显著差异(P<0.05),且观察组起效时间明显优于对照组(P<0.05)。结论贝尔面瘫常规治疗配合同步鼓室内糖皮质激素注射治疗,起效快、疗效好,值得临床推广。 展开更多
关键词 糖皮质激素 鼓室注射 贝尔面瘫 疗效
下载PDF
二陈汤与血府逐瘀汤治疗肺结节患者的有效性
17
作者 张晓琳 薛均来 《世界复合医学》 2023年第7期127-130,共4页
目的探究二陈汤联合血府逐瘀汤对肺结节的治疗效果。方法选取2020年1月—2022年10月长春市中心医院所收治的肺结节患者212例为研究对象,根据随机数表法分为西药组(采用糖皮质激素治疗)和中药组(在西药组基础上采用二陈汤联合血府逐瘀汤... 目的探究二陈汤联合血府逐瘀汤对肺结节的治疗效果。方法选取2020年1月—2022年10月长春市中心医院所收治的肺结节患者212例为研究对象,根据随机数表法分为西药组(采用糖皮质激素治疗)和中药组(在西药组基础上采用二陈汤联合血府逐瘀汤治疗),每组106例。对比两组治疗前后肺结节临床症状变化情况、肺功能改善情况、医学影像检测结果、治疗有效率以及药物不良反应发生情况。结果治疗后,中药组肺结节症状改善情况明显优于西药组,差异有统计学意义(P<0.05)。中药组肺功能改善情况明显优于西药组,差异有统计学意义(P<0.05)。中药组医学影像检测结果明显优于西药组,差异有统计学意义(P<0.05)。中药组治疗有效率为91.51%明显优于西药组的73.58%,差异有统计学意义(χ^(2)=8.219,P<0.05)。结论二陈汤和血府逐瘀汤是两剂经典的中药方,对肺部相关疾病具有理想的治疗效果,对肺结节具有良好的治疗效果。 展开更多
关键词 肺结节 二陈汤 血府逐瘀汤 糖皮质激素 治疗效果
下载PDF
糖皮质激素配合特布他林治疗慢阻肺急性加重期合并糖尿病的疗效分析 被引量:5
18
作者 周荃 《中外医疗》 2023年第29期112-114,122,共4页
目的分析糖皮质激素配合特布他林治疗慢性阻塞性肺疾病(慢阻肺)急性加重期合并糖尿病的效果。方法随机选取2021年1月—2023年6月江苏省仪征市人民医院呼吸与危重症科收治的慢阻肺急性加重期合并糖尿病患者80例为研究对象。基于信封法分... 目的分析糖皮质激素配合特布他林治疗慢性阻塞性肺疾病(慢阻肺)急性加重期合并糖尿病的效果。方法随机选取2021年1月—2023年6月江苏省仪征市人民医院呼吸与危重症科收治的慢阻肺急性加重期合并糖尿病患者80例为研究对象。基于信封法分为对照组和观察组,对照组40例实行二甲双胍+布地奈德雾化治疗,观察组40例实行二甲双胍+特布他林雾化+布地奈德雾化治疗。对比两组患者血糖指标、肺通气指标和临床治疗效果。结果治疗后,两组血糖指标均较治疗前降低,差异有统计学意义(P<0.05),但两组血糖指标比较,差异无统计学意义(P>0.05)。治疗后,观察组肺通气指标优于对照组,差异有统计学意义(P<0.05)。观察组治疗总有效率(97.50%)高于对照组(80.00%),差异有统计学意义(χ2=6.135,P=0.013)。结论糖皮质激素与特布他林联合雾化用在慢阻肺急性加重期合并糖尿病患者治疗中的优势突出,可良好改善患者血糖与肺部功能,治疗效果显著。 展开更多
关键词 糖皮质激素 特布他林 慢性阻塞性肺疾病急性加重期 糖尿病 治疗效果
下载PDF
The role of drug utilization evaluation in medical sciences
19
作者 Ruby Gangwar Arvind Kumar +2 位作者 Abrar Ahmed Zargar Amit Sharma Ranjeet Kumar 《Global Health Journal》 2023年第1期3-8,共6页
Background:Drug utilization evaluation(DUE)is defined by the World Health Organization(WHO)and focuses on the medical,social,and economic consequences of pharmaceutical marketing,distribution,prescribing,and usage in ... Background:Drug utilization evaluation(DUE)is defined by the World Health Organization(WHO)and focuses on the medical,social,and economic consequences of pharmaceutical marketing,distribution,prescribing,and usage in society.The WHO recommends a physician to every 1000 people.According to the recent data from the Health Ministry in 2019,in which 1.16 million doctors are of active population with just 80%,or 0.9 million,practicing.As a result,a ratio of 0.68 doctors for every 1000 people,which is much below as per the WHO reports.This article describes history,types,WHO guidelines,need and purpose of DUE.Objective:The main aim of this paper is to provide information about the rational use of medication in outpa­tient and inpatient department with special emphasis of DUEs.It also provides awareness directly to healthcare professionals,researchers,academicians,pharmacist and nurses to reduce the irrationality of medicines.Methods:The method used to compile this review information gathered from websites,Google scholar,PubMed,Research gate,and studies published on DUE from July 20 to Oct 22 were included as source of information.Results:We studied more than 35 published study on DUE,that reveals most of the physicians prescribed branded drugs not generic drugs,but WHO prescribing indicator allows to prescribe generic drugs in the hospital pharmacy to maintain better inventory control.It may also help to prevent pharmacist misunderstanding during dispensing.Conclusion:The use of generic prescription names avoids the possibility of medication product duplication and lowers patient costs.It is important to remember that incorrect medication prescriptions have impact on both patients and their family members.WHO indicators identify irrational prescribing behaviours to make therapy more rational and cost-effective. 展开更多
关键词 Anatomical therapeutic chemical classification Drug utilization evaluation Prescribing indicators Pregnancy risk classification Rational use of the drug
下载PDF
Clinical evidence of an interferon-glucocorticoid therapeutic synergy in COVID-19
20
作者 Yingying Lu Feng Liu +9 位作者 Gangling Tong Feng Qiu Pinhong Song Xiaolin Wang Xiafei Zou Deyun Wan Miao Cui Yunsheng Xu Zhihua Zheng Peng Hong 《Signal Transduction and Targeted Therapy》 SCIE CSCD 2021年第4期1254-1264,共11页
Synthetic glucocorticoid dexamethasone is the first trial-proven drug that reduces COVID-19 mortality by suppressing immune system.In contrast,interferons are a crucial component of host antiviral immunity and can be ... Synthetic glucocorticoid dexamethasone is the first trial-proven drug that reduces COVID-19 mortality by suppressing immune system.In contrast,interferons are a crucial component of host antiviral immunity and can be directly suppressed by glucocorticoids.To investigate whether therapeutic interferons can compensate glucocorticoids-induced loss of antiviral immunity,we retrospectively analyzed a cohort of 387 PCR-confirmed COVID-19 patients with quasi-random exposure to interferons and conditional exposure to glucocorticoids.Among patients receiving glucocorticoids,early interferon therapy was associated with earlier hospital discharge(adjusted HR 1.68,95%Cl 1.19-2.37)and symptom relief(adjusted HR 1.48;95%Cl 1.06-2.08),while these associations were insignificant among glucocorticoids nonusers.Early interferon therapy was also associated with lower prevalence of prolonged viral shedding(adjusted OR 0.24,95%Cl 0.10-0.57)only among glucocorticoids users.Additionally,these associations were glucocorticoid cumulative dose-and timing-dependent.These findings reveal potential therapeutic synergy between interferons and glucocorticoids in COVID-19 that warrants further investigation. 展开更多
关键词 glucocorticoid therapeutic IMMUNITY
原文传递
上一页 1 2 8 下一页 到第
使用帮助 返回顶部